Mammary gland development in transforming growth factor beta1 null mutant mice: Systemic and epithelial effects

Biology of Reproduction

Volumn 79, Issue 4, 2008, Pages 711-717

  Ingman, Wendy V ^a   Robertson, Sarah A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cytokines; Development; Developmental biology; Epithelium; Mammary glands; Transforming growth factor beta1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADIPOSE TISSUE; ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; BREAST DUCT; BREAST EPITHELIUM; CELL DIFFERENTIATION; CONTROLLED STUDY; DIESTRUS; ENDOCRINE FUNCTION; FEMALE; GENOTYPE; LUNG ALVEOLUS; MORPHOGENESIS; MORPHOLOGY; MOUSE; NONHUMAN; OVARY CYCLE; PARACRINE SIGNALING; PRIORITY JOURNAL; PUBERTY; TISSUE DIFFERENTIATION;

ANIMALS; AUTOCRINE COMMUNICATION; EPITHELIUM; ESTRUS; FEMALE; MALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOGENESIS; PARACRINE COMMUNICATION; PREGNANCY; SEXUAL MATURATION; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; MUS;

EID: 53349129756     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.107.067272     Document Type: Article

References (35)

1. Hovey RC, Trott JF, Vonderhaar BK. Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 2002; 7:17-38.
2. Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ, Soloway P, Itohara S, Werb Z. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 2003; 162:1123-1133.
3. Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ. The interplay of matrix metalloproteinases, morphogens, and growth factors is necessary for branching of mammary epithelial cells. Development 2001; 128:3117-3131.
4. Fata JE, Chaudhary V, Khokha R. Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle. Biol Reprod 2001; 65:680-688.
5. Fleisch MC, Maxwell CA, Barcellos-Hoff MH. The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs. Endocr Relat Cancer 2006; 13:379-400.
6. Serra R, Crowley MR. Mouse models of transforming growth factor beta impact in breast development and cancer. Endocr Relat Cancer 2005; 12:749-760.
7. Daniel CW, Robinson S, Silberstein GB. The transforming growth factors beta in development and functional differentiation of the mouse mammary gland. Adv Exp Med Biol 2001; 501:61-70.
8. Robinson SD, Silberstein GB, Roberts AB, Flanders KC, Daniel CW. Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development 1991; 113:867-878.
9. Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ, Moses HL. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res 2005; 65:2296-2302.
10. Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA, Moses HL. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am J Pathol 2003; 163:1539-1549.
11. Gorska AE, Joseph H, Derynck R, Moses HL, Serra R. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 1998; 9:229-238.
12. Joseph H, Gorska AE, Sohn P, Moses HL, Serra R. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol Biol Cell 1999; 10:1221-1234.
13. Ewan KB, Shyamala G, Ravani SA, Tang Y, Akhurst R, Wakefield L, Barcellos-Hoff MH. Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol 2002; 160:2081-2093.
14. Nelson CM, Vanduijn MM, Inman JL, Fletcher DA, Bissell MJ. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 2006; 314:298-300.
15. Kulkarni AB, Huh C, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993; 90:770-774.
16. Shull MM, Ormsby I, Kier AB, Pawlowski SA, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. Targeted disruption of the mouse transforming growth factor β1 gene results in multifocal inflammatory disease. Nature 1992; 359:693-699.
17. Diebold RJ, Eis MJ, Yin M, Ormsby I, Boivin GP, Darrow BJ, Saffitz JE, Doetschman T. Early onset multifocal inflammation in the transforming growth factor beta1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A 1995; 92:12215-12219.
18. Ingman WV, Robker RL, Woittiez K, Robertson SA. Null mutation in transforming growth factor beta1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest. Endocrinology 2006; 147:835-845.
19. Allen E. The estrous cycle in the mouse. Am J Anat 1921; 30:297-348.
20. Robinson G. Biology of the Mammary Gland. U.S. National Institutes of Health, Bethesda, Maryland, USA, http://mammary.nih.gov/tools/histological/ Histology/index.html. 1999-2008. (April, 2003).
21. Rasband WS. ImageJ. U.S. National Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/. 1997-2007. (July, 2005).
22. Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999; 20:358-417.
23. Flux DS. Growth of the mammary duct system in intact and ovariectomized mice of the CHI strain. J Endocrinol 1954; 11:223-237.
24. Atwood CS, Hovey RC, Glover JP, Chepko G, Ginsburg E, Robison WG, Vonderhaar BK. Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J Endocrinol 2000; 167:39-52.
25. Silberstein GB, Daniel CW. Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science 1987; 237:291-293.
26. Pierce DF Jr, Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF, Daniel CW, Hogan BL, Moses HL. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta1. Genes Dev 1993; 7:2308-2317.
27. Yang YA, Tang B, Robinson G, Hennighausen L, Brodie SG, Deng CX, Wakefield LM. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta. Cell Growth Differ 2002; 13:123-130.
28. Roarty K, Serra R. Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth. Development 2007; 134:3929-3939.
29. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, Arteaga CL, Neilson EG, Hayward SW, Moses HL. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP-, and HGF-mediated signaling networks. Oncogene 2005; 24:5053-5068.
30. Gouon Evans V, Rothenberg ME, Pollard JW. Postnatal mammary gland development requires macrophages and eosinophils. Development 2000; 127:2269-2282.
31. Bonyadi M, Rusholme SA, Cousins FM, Su HC, Biron CA, Farrall M, Akhurst RJ. Mapping of a major genetic modifier of embryonic lethality in TGF beta1 knockout mice. Nat Genet 1997; 15:207-211.
32. Tang Y, Lee KS, Yang H, Logan DW, Wang S, McKinnon ML, Holt LJ, Condie A, Luu MT, Akhurst RJ. Epistatic interactions between modifier genes confer strain-specific redundancy for Tgfb1 in developmental angiogenesis. Genomics 2005; 85:60-70.
33. Tang Y, McKinnon ML, Leong LM, Rusholme SA, Wang S, Akhurst RJ. Genetic modifiers interact with maternal determinants in vascular development of Tgfb1(-/-) mice. Hum Mol Genet 2003; 12:1579-1589.
34. Jakowlew SB. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 2006; 25:435-457.
35. Bachman KE, Park BH. Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol 2005; 17:49-54.